Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Wang, Guang Wu ^a   Zhou, Zhanxiang ^a   Klein, Jon B ^a,b   Kang, Y James ^a,c  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Caspase 3 activation; Cell culture; Cell death; Cytochrome c release

Indexed keywords

CASPASE 3; CYTOCHROME C; LACTATE DEHYDROGENASE; METALLOTHIONEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HEART MUSCLE CELL; HYPOXIA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION;

EID: 0035031486     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.5.h2292     Document Type: Article

References (54)

1. Abel J and de Ruiter N. Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein. Toxicol Lett 47: 191-196, 1989.
2. Altschuld R, Gibb L, Ansel A, Hohl C, Kruger Fe, and Brierley GP. Calcium tolerance of isolated rat heart cells. J Mol Cell Cardiol 12: 1383-1395, 1980.
3. Becker LC and Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 30: 23-44, 1987.
4. Bloom S. Requirements for spontaneous contractility in isolated adult mammalian heart muscle cells. Exp Cell Res 69: 17-24, 1971.
5. Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, and McCay PB. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 65: 607-622, 1989.
6. Brady FO and Helvig B. Effect of epinephrine and norepinephrine on zinc thionein levels and induction in rat liver. Am J Physlol Endocrinol Metab 247: E318-E322, 1984.
7. Cai L, Klein JB, and Kang YJ. Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J Biol Chem 275: 38957-38960, 2000.
8. Curello S, Ceconi C, de Giuli F, Panzali AF, Milanesi B, Calarco M, Pardini A, Marzollo P, Alfieri O, Messineo F, and Ferrari R. Oxidative stress during reperfusion of human hearts; potential sources of oxygen free radicals. Cardiovasc Res 29: 118-125, 1995.
9. Eaton DL and Cherian MG. Determination of metallothionein in tissue by cadmium-hemoglobin affinity assay. Methods Enzymol 205: 83-88, 1991.
10. Ferrari R. Metabolic disturbances during myocardial ischemia and reperfusion. Am J Cardiol 76: 17B-24B, 1995.
11. Fliss H and Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Cire Res 79: 949-956, 1996.
12. Garcia-Ruiz C, Colell A, Paris R, and Fernandez-Checa JC. Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J 14: 847-858, 2000.
13. Gottlieb RA and Engler RL. Apoptosis in myocardial ischemia-reperfusion. Ann NY Acad Sci 874: 412-426, 1999.
14. Green DR and Reed JC. Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
15. Gross GJ, Farber NE, Hardman HF, and Warltier DC. Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol Heart Circ Physiol 250: H372-H377, 1986.
16. Hamer DH. Metallothionein. Annu Rev Biochem 55: 913-951, 1986.
17. Jeroudi MO, Hartley CJ, and Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol 73: 2B-7B, 1994.
18. Kagi JHR. Overview of metallothionein. Methods Enzymol 205: 613-626, 1991.
19. Kajsture J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, and Anversa P. Apoptosis and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107, 1996.
20. Kang YJ. The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 222: 263-273, 1999.
21. Kang YJ, Chen Y, Yu A, Voss-McCowan M, and Epstein PN. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 100: 1501-1506, 1997.
22. Kang YJ, Li G, and Saari JT. Metallothionein inhibits ischemia-reperfusion injury in mouse heart. Am J Physiol Heart Circ Physiol 276: H993-H997, 1999.
23. Kang YJ, Zhou ZX, Wang GW, Buridi A, and Klein JB. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 275: 13690-13698, 2000.
24. Kang YJ, Zhou ZX, Wu HY, Wang GW, Saari JT, and Klein JB. Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest 80: 745-757, 2000.
25. L inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res 57: 3115-3120, 1997.
26. Kondo Y, Rusnak JM, Hoyt DG, Settineri CE, Pitt BR, and Lazo JS. Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 52: 195-201, 1997.
27. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Almemri ES, and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
28. Liu X, Kim CN, Yang J, Jemmerson R, and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996.
29. Lucas DT and Szweda LI. Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc Natl Acad Sci USA 95: 510-514, 1998.
30. Lucchesi BR. Myocardial ischemia, reperfusion and free radical injury. Am J Cardiol 65: 141-231, 1990.
31. Malhotra R and Brosius FC III. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem 274: 12567-12575, 1999.
32. Manning AS, Coltart DJ, and Hearse DJ. Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res 55: 544-548, 1984.
33. Naganuma A, Satoh M, and Imura N. Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice. Jpn J Cancer Res 79: 406-411, 1988.
34. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Bello BD, Semigran MJ, Bielsa-Masdeu A, Dec GW, Israels S, Ballester M, Virmani R, Saxena S, and Kharbanda S. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96: 8144-8149, 1999.
35. Pan G, Humke EW, and Dixit VM. Activation of caspase triggered by cytochrome c in vitro. FEBS Lett 426: 151-154, 1998.
36. 2 with sulfhydryl groups in HL-60 cells: zinc-metallothionein and other sites. Arch Biochem Biophys 334: 241-250, 1996.
37. Saikumar P, Dong Z, Weinberg JM, and Venkatachalam MA. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 17: 3341-3349, 1998.
38. Sato M, Sasaki M, and Hojo H. Differential induction of metallothionein synthesis by interleukin-6 and tumor necrosis factor-alpha in rat tissues. Int J Immunopharmacol 16: 187-195, 1994.
39. Satoh M, Naganuma A, and Imura N. Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination. Cancer Chemother Pharmacol 21: 176-178, 1988.
40. Tamura Y, Chi L, Driscoll EJ Jr, Hott PT, Freeman BM, Gallagher KP, and Lucchesi BR. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia-reperfusion injury in canine heart. Circ Res 63: 944-959, 1988.
41. Templeton DM and Cherian MG. Toxicological significance of metallothionein. Methods Enzymol 205: 11-24, 1991.
42. Thomas JP, Bachowski GL, and Girotti AW. Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothionein. Biochim Biophys Acta 884: 448-461, 1986.
43. Thornalley PJ and Vasak M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 827: 36-44, 1985.
44. Tsangaris GT and Tzortzatou-Statopoulou F. Metallothionein expression prevents apoptosis: a study with antisense phosphorothioate oligodeoxynucleotides in human T cell line. Anticancer Res 18: 2423-2433, 1998.
45. von Harsdorf R, Li PF, and Dietz R. Signaling pathway in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99: 2934-2941, 1999.
46. Wang GW and Kang YJ. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels. J Pharmacol Exp Ther 288: 938-944, 1999.
47. 2 toxicity. Am J Physiol Heart Circ Physiol 276: H167-H175, 1999.
48. Welder AA, Grant R, Bradlaw J, and Acosta D. A primary culture system of adult rat heart cells for the study of toxicologic agent. In Vitro Cell Dev Biol 27A: 921-926, 1991.
49. Wu HY and Kang YJ. Inhibition of buthionein sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart. J Pharmacol Exp Ther 287: 515-520, 1998.
50. Yang BC, Zander DS, and Mehta JL. Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-β1. J Pharmacol Exp Ther 291: 733-738, 1999.
51. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T, Jones DP, and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
52. Young HH, Shimizu T, Nishioka K, Nakanishi T, and Jarmakani JM. Effect of hypoxia and reoxygenation on mitochondrial function in neonatal myocardium. Am J Physiol Heart Circ Physiol 245: H998-H1006, 1983.
53. Zhou ZX and Kang YJ. Immunocytochemical localization of metallothionein and its relation to doxorubicin toxicity in transgenic mouse heart. Am J Pathol 156: 1653-1662, 2000.
54. Zhuang S, Lynch MC, and Kochevar IE. Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells. Exp Cell Res 250: 203-212, 1999.